Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

40%(2 trials)

Phase Distribution

Ph not_applicable

20%

Ph phase_1

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

4(80.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 14 (80.0%)

N/A1 (20.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_1

A Study of Milvexian in Healthy Adult Females

NCT05706753

completednot_applicable

Phlebotomy and Polycystic Ovary Syndrome

NCT02460445

completedphase_1

A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone

NCT02652650

completedphase_1

Drug-drug Interaction of BI 201335 and Microgynon

NCT01570244

completedphase_1

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

NCT01328184

Clinical Trials (5)

Showing 5 of 5 trials

NCT05706753Phase 1

A Study of Milvexian in Healthy Adult Females

Completed

NCT02460445Not Applicable

Phlebotomy and Polycystic Ovary Syndrome

Completed

NCT02652650Phase 1

A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone

Completed

NCT01570244Phase 1

Drug-drug Interaction of BI 201335 and Microgynon

Completed

NCT01328184Phase 1

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5